Biomarkers of Cisplatin Resistance in Urothelial Bladder Cancer: HMGA2 and Survivin

被引：0
|
作者：
Reis, Henning [1 ]
Krafft, Ulrich [1 ]
Tschirdewahn, Stephan [1 ]
Hess, Jochen [1 ]
Harke, Nina [1 ]
Hadaschik, Boris [2 ]
Krege, Susanne [3 ]
Nyirady, Peter [4 ]
Szendroi, Attila [4 ]
Szucs, Miklos [4 ]
Modos, Orsolya [5 ]
Szekely, Eszter [6 ]
Szarvas, Tibor [1 ,4 ]
Szarvas, Tibor [1 ,4 ]
机构：
[1] Univ Duisburg Essen, West German Canc Ctr, Essen, Germany
[2] Univ Duisburg Essen, Univ Hosp Essen, Essen, Germany
[3] Kliniken Essen Mitte, Essen, Germany
[4] Semmelweis Univ, Budapest, Hungary
[5] Semmelweis Univ, Clin Urol, Budapest, BP, Hungary
[6] Semmelweis Univ, Univ Hosp Budapest, Budapest, Hungary
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
938
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Overexpression of HMGA2 as a prognostic indicator in breast cancer.
    Wang, Xiaochen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] HMGA2 ACTS AS A ceRNA TO STIMULATE LUNG CANCER METASTASIS
    不详
    CANCER DISCOVERY, 2014, 4 (02) : 141 - 141
  • [33] Aberrant HMGA2 Expression Sustains Genome Instability That Promotes Metastasis and Therapeutic Resistance in Colorectal Cancer
    Campos Gudino, Rubi
    McManus, Kirk J.
    Hombach-Klonisch, Sabine
    CANCERS, 2023, 15 (06)
  • [34] Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer
    Shi, Zhan
    Li, Xiang
    Wu, Ding
    Tang, Run
    Chen, Renfu
    Xue, Song
    Sun, Xiaoqing
    TUMOR BIOLOGY, 2016, 37 (06) : 7515 - 7523
  • [35] HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer
    Mansoori, Behzad
    Terp, Mikkel Green
    Mohammadi, Ali
    Pedersen, Christina Bog
    Ditzel, Henrik Jorn
    Baradaran, Behzad
    Gjerstorff, Morten Frier
    CANCERS, 2021, 13 (20)
  • [36] LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis
    Miao, Jin-Tian
    Gao, Jian-Hua
    Chen, Yong-Qian
    Chen, Hong
    Meng, Hao-Yi
    Lou, Ge
    BIOSCIENCE REPORTS, 2019, 39
  • [37] HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
    Hashemi, Mehrdad
    Rashidi, Mohsen
    Hushmandi, Kiavash
    ten Hagen, Timo L. M.
    Salimimoghadam, Shokooh
    Taheriazam, Afshin
    Entezari, Maliheh
    Falahati, Mojtaba
    PHARMACOLOGICAL RESEARCH, 2023, 190
  • [38] Role of high mobility group A2 (HMGA2) in prostate cancer
    Hawsawi, Ohuod A.
    Burton, Liza
    Dougan, Jodi
    Millena, Ana Cecillia
    Nagappan, Peri
    Khan, Shafiq
    Odero-Marah, Valerie
    CANCER RESEARCH, 2018, 78 (13)
  • [39] CircRNAs as upstream regulators of miRNA//HMGA2 axis in human cancer
    Sun, Qiqi
    Lei, Xiaoyong
    Yang, Xiaoyan
    PHARMACOLOGY & THERAPEUTICS, 2024, 263
  • [40] HMGA2 as new prognostic marker of squamous cancer of the oral cavity
    Loeschke, S.
    Ohlmann, A.
    Brasen, J.
    Rene, H.
    Warnke, P.
    VIRCHOWS ARCHIV, 2014, 465 : S33 - S33
12345